Literature DB >> 482863

Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases.

S Iwarson, J Lindberg, P Lundin.   

Abstract

Adverse liver reactions associated with nitrofurantoin treatment are rare but important complications. Both acute and chronic liver damage have been described. The present report describes five patients who developed chronic liver disease after 1 to 3 years of continued nitrofurantoin treatment. Liver histology was consistent with chronic active hepatitis in four patients, while postnecrotic cirrhosis was observed in one case. Follow-up examinations 2 to 3 years after withdrawal of the drug showed marked improvement clinically and in most cases also histologically.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 482863

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Authors:  Omar Khokhar; Christopher Gange; Stephen Clement; James Lewis
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

2.  Nitrofurantoin rechallenge and recurrent toxicity.

Authors:  M C Bialas; H G Shetty; J Houghton; F Woods; P A Routledge
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

3.  Drug-induced Liver Injury.

Authors:  Stefan David; James P Hamilton
Journal:  US Gastroenterol Hepatol Rev       Date:  2010-01-01

Review 4.  Antibacterial-induced hepatotoxicity. Incidence, prevention and management.

Authors:  D K George; D H Crawford
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

5.  Autoimmune hepatitis induced by nitrofurantoin. The importance of the autoantibodies for an early diagnosis of immune disease.

Authors:  Jagannath M Sherigar; Richard Fazio; Minsheng Zuang; Edward Arsura
Journal:  Clin Pract       Date:  2012-10-17

6.  Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.

Authors:  David E Kleiner; Naga P Chalasani; William M Lee; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Paul H Hayashi; Timothy J Davern; Victor Navarro; Rajender Reddy; Jayant A Talwalkar; Andrew Stolz; Jiezhun Gu; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2013-12-18       Impact factor: 17.425

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.